bupropion hydrochloride (xl) (76282-480)

Drug Facts

Product Profile

Brand Name bupropion hydrochloride (xl)

Generic Name bupropion hydrochloride

Labeler exelan pharmaceuticals inc.

Dosage Form TABLET, EXTENDED RELEASE

Routes

ORAL

Active Ingredients

bupropion hydrochloride 150 mg/1

Manufacturer

Exelan Pharmaceuticals Inc.

Identifiers & Regulatory

Product NDC 76282-480

Product ID 76282-480_9fff6e28-19e0-43ad-85c8-57d111b990bb

Product Type HUMAN PRESCRIPTION DRUG

Marketing Category ANDA

Application Number ANDA206556

Listing Expiration 2026-12-31

Marketing Start 2019-02-01

Pharmacologic Class

Classes

aminoketone [epc] dopamine uptake inhibitors [moa] increased dopamine activity [pe] increased norepinephrine activity [pe] norepinephrine uptake inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 76282480

Hyphenated Format 76282-480

Supplemental Identifiers

RxCUI

993541 993557

UPC

0376282481050 0376282480053 0376282481302 0376282480305 0376282480909 0376282481906

UNII

ZG7E5POY8O

Packaging Origin

Original Packager

true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name bupropion hydrochloride (xl) (source: ndc)

Generic Name bupropion hydrochloride (source: ndc)

Application Number ANDA206556 (source: ndc)

Routes

ORAL

source: ndc

Resolved Composition

Strengths

150 mg/1

source: ndc

Packaging

500 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-480-05)
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-480-30)
90 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-480-90)

source: ndc

Packages (3)

76282-480-05 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-480-05) 76282-480-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-480-30) 76282-480-90 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-480-90)

Ingredients (1)

bupropion hydrochloride (150 mg/1)

Linked Drug Pages (1)

Bupropion Hydrochloride (XL) ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload

{"route": ["ORAL"], "spl_id": "9fff6e28-19e0-43ad-85c8-57d111b990bb", "openfda": {"upc": ["0376282481050", "0376282480053", "0376282481302", "0376282480305", "0376282480909", "0376282481906"], "unii": ["ZG7E5POY8O"], "rxcui": ["993541", "993557"], "spl_set_id": ["8a0781c0-e7d5-498e-b7d3-d6bd457f175f"], "manufacturer_name": ["Exelan Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-480-05)", "package_ndc": "76282-480-05", "marketing_start_date": "20190201"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-480-30)", "package_ndc": "76282-480-30", "marketing_start_date": "20220210"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-480-90)", "package_ndc": "76282-480-90", "marketing_start_date": "20220210"}], "brand_name": "Bupropion Hydrochloride (XL)", "product_id": "76282-480_9fff6e28-19e0-43ad-85c8-57d111b990bb", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "76282-480", "generic_name": "bupropion hydrochloride", "labeler_name": "Exelan Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "(XL)", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA206556", "marketing_category": "ANDA", "marketing_start_date": "20190201", "listing_expiration_date": "20261231"}